Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients
- PMID: 1981108
- DOI: 10.1093/schbul/16.3.477
Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients
Abstract
We have reviewed the literature from the 1950's to the present on the effects of neuroleptics on perceptual and neuropsychological function in chronic schizophrenic patients. In contrast to previous reviews, we have delineated the acute and chronic effects of neuroleptics on individual cognitive and motor tasks by drug, dose, and length of administration. To date, studies have shown that acute administration of neuroleptics impairs performance on some, but not all, tasks requiring vigilance and attention, and on some tasks requiring motor behavior. Chronic administration of neuroleptics, however, improves performance on some tasks requiring sustained attention and visuomotor problem-solving skills depending on dose and length of administration. Moreover, there is consistent evidence to suggest that chronic administration of neuroleptics in this patient population does not impair neuropsychological function independent of motor function. These findings have direct implications regarding the risk/benefit ratio and legal ramifications for the use of neuroleptics in chronic schizophrenic patients.
Similar articles
-
Negative and deficit symptoms in schizophrenia do respond to neuroleptics.Schizophr Bull. 1985;11(3):453-6. doi: 10.1093/schbul/11.3.453. Schizophr Bull. 1985. PMID: 2863872
-
[Tolerance of neuroleptics, deficit syndrome and cognitive functions].Encephale. 1996 Jun;22 Spec No 2:49-54. Encephale. 1996. PMID: 8767043 Review. French.
-
Gender differences in cognition in schizophrenia.Schizophr Res. 1992 Oct;8(1):69-73. doi: 10.1016/0920-9964(92)90062-a. Schizophr Res. 1992. PMID: 1358186
-
Neurocognitive subtypes of chronic schizophrenia.Schizophr Res. 1993 Mar;9(1):49-58. doi: 10.1016/0920-9964(93)90009-8. Schizophr Res. 1993. PMID: 8096391
-
Psychomotor impairment and cognitive disturbances induced by neuroleptics.Acta Psychiatr Scand Suppl. 1994;380:53-8. doi: 10.1111/j.1600-0447.1994.tb05833.x. Acta Psychiatr Scand Suppl. 1994. PMID: 7914050 Review.
Cited by
-
Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2007 Jun;257(4):203-10. doi: 10.1007/s00406-006-0707-x. Epub 2006 Nov 25. Eur Arch Psychiatry Clin Neurosci. 2007. PMID: 17131214
-
Antipsychotics in older patients. A safety perspective.Drugs Aging. 1995 Apr;6(4):312-23. doi: 10.2165/00002512-199506040-00006. Drugs Aging. 1995. PMID: 7613020 Review.
-
Recent advances in treating cognitive impairment in schizophrenia.Psychopharmacology (Berl). 2009 Jan;202(1-3):259-73. doi: 10.1007/s00213-008-1302-9. Epub 2008 Sep 3. Psychopharmacology (Berl). 2009. PMID: 18766331 Review.
-
Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1753-64. doi: 10.1016/j.pnpbp.2011.06.004. Epub 2011 Jun 13. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21689713 Free PMC article. Clinical Trial.
-
Clinical neuropsychological characteristics of bipolar disorder, with a focus on cognitive and linguistic pattern: a conceptual analysis.F1000Res. 2023 Sep 27;12:1235. doi: 10.12688/f1000research.141599.1. eCollection 2023. F1000Res. 2023. PMID: 38434643 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical